If Quest Diagnostics is struggling to find viable investments, it always has the option to increase its payout ratio to pay more to shareholders. Overall, a dividend increase is always good ...

This represents a $3.20 dividend on an annualized basis and a yield of 1.95%. This is an increase from Quest Diagnostics’s previous quarterly dividend of $0.75. The ex-dividend date of this ...

Moreover, Quest Diagnostics has increased its quarterly dividend by 6.7%, to $0.80 per share. In terms of analyst outlook, Jefferies has maintained their Buy rating for Quest Diagnostics and ...

(RTTNews) - Quest Diagnostics (DGX) revealed a profit for its first quarter that increased from last year and beat the Street estimates. The company's earnings came in at $220 million, or $1.94 ...

Baird analyst Eric Coldwell maintained Quest Diagnostics with an Outperform rating and raised the price target from $191 to ...

alongside its collaboration with GRAIL and a 6.7% dividend increase, provided a counterbalance to the volatile market conditions. While the healthcare sector... Quest Diagnostics (NYSE ...

Quest Diagnostics (DGX) reports 12% Q1 2025 revenue growth, driven by acquisitions, partnerships, and advanced diagnostics.

Return on Equity (ROE): Quest Diagnostics's ROE is below industry standards, pointing towards difficulties in efficiently ...

While growth may be thin on the ground, Quest Diagnostics could always pay out a higher proportion of earnings to increase shareholder returns. Overall, a dividend increase is always good, and we ...

If Quest Diagnostics is struggling to find viable investments, it always has the option to increase its payout ratio to pay more to shareholders. Overall, a dividend increase is always good, and we ...